We will be happy to assist
CONTACT US TO
FIND OUT MORE
AXON Dx develops instruments and reagents for the rapid, minimally invasive analysis of circulating tumor cells (CTCs). For inquiries related to our technology, research collaborations, or general information, please contact our team using the form below.
Get in touch with our team!
We use your information only to respond to your inquiry.
FAQ
Most frequent questions and answers
AXON Dx develops instruments and reagents designed for rapid, minimally invasive analysis of circulating tumor cells (CTCs) from a simple blood draw.
CTCs provide insight into tumor behavior and disease progression, allowing researchers to study cancer biology using a minimally invasive sample.
No. AXON Dx develops diagnostic tools and research technologies but does not offer clinical testing services to patients.
CTCs are extremely rare—often only 1–10 cells per milliliter of whole blood—requiring highly sensitive analytical methods to identify them among millions of nucleated blood cells.
AXON Dx is headquartered in Virginia, USA.